Short-term pulmonary and systemic effects of hydrocortisone initiated 7-14 days after birth in ventilated very preterm infants: a secondary analysis of a randomised controlled trial

Short-term pulmonary and systemic effects of hydrocortisone initiated 7-14 days after birth in ventilated very preterm infants: a secondary analysis of a randomised controlled trial

Objective Observational studies in preterm infants suggest that systemic hydrocortisone improves pulmonary condition but may also lead to systemic adverse effects. We report the short-term pulmonary and systemic effects of hydrocortisone initiated in the second week.Design Randomised placebo-control...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of Disease in Childhood. Fetal and Neonatal Edition 2022-05, Vol.108 (1), p.F20-F25
Hauptverfasser: Halbmeijer, N.M., Onland, W., Cools, F., Kroon, A., Heide-jalving, M. van der, Dijk, P., Straaten, H.L.M. van, Pas, A.B. te, Mohns, T., Bruneel, E., Heijst, A.F.J. van, Kramer, B., Debeer, A., Zonnenberg, I.A., Marechal, Y., Blom, H., Plaskie, K., Merkus, M.P., Offringa, M., Kaam, A.H. van
Format: Artikel
Sprache:eng
Schlagworte:
Neonatology
Respiratory Medicine
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective Observational studies in preterm infants suggest that systemic hydrocortisone improves pulmonary condition but may also lead to systemic adverse effects. We report the short-term pulmonary and systemic effects of hydrocortisone initiated in the second week.Design Randomised placebo-controlled trial.Setting Dutch and Belgian neonatal intensive care units.Patients Infants born
DOI:10.1136/archdischild-2022-323882